| Identification | Back Directory | [Name]
N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide | [CAS]
847494-64-8 | [Synonyms]
MQRLCCDKPUEHCQ-ABRLXTPQSA-N
N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide
2-Pyridinecarboxamide, N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl- | [Molecular Formula]
C31H42BN3O5 | [MDL Number]
MFCD31562007 | [MOL File]
847494-64-8.mol | [Molecular Weight]
547.49 |
| Chemical Properties | Back Directory | [Boiling point ]
726.0±60.0 °C(Predicted) | [density ]
1.20±0.1 g/cm3(Predicted) | [solubility ]
Chloroform, DCM, Methanol | [form ]
Solid | [pka]
11.93±0.46(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide is an intermediate in the synthesis of Delanzomib (D230710), an orally active proteasome inhibitor. |
|
|